USPTO Affirms Claims of Patent Held by Genetic Technologies | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies today said that the US Patent and Trademark Office has affirmed the validity of certain claims of a primary non-coding DNA patent held by the Australian firm.

In a formal notification to Genetic Technologies, the USPTO states that certain claims of US Patent No. 5,612,179 "are confirmed" while other claims "are not re-examined," Genetic Technologies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.